Automated subcellular localization and quantification of protein expression in tissue microarrays

Nature Medicine

Volumn 8, Issue 11, 2002, Pages 1323-1327

  Camp, Robert L ^a   Chung, Gina G ^a   Rimm, David L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; ESTROGEN RECEPTOR;

ARTICLE; AUTOMATION; BREAST CARCINOMA; CANCER TISSUE; COLON CANCER; DNA MICROARRAY; HUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SIGNAL PROCESSING; TISSUE SECTION;

ALGORITHMS; BETA CATENIN; CELL COMPARTMENTATION; CYTOSKELETAL PROTEINS; NEOPLASMS; PROTEINS; SUBCELLULAR FRACTIONS; TRANS-ACTIVATORS;

EID: 0036852721     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm791     Document Type: Article

References (19)

1. Tarnok, A. & Gerstner, A.O. Clinical applications of laser scanning cytometry. Cytometry 50, 133-143 (2002).
2. Robinson, J.P. Principles of confocal microscopy. Methods Cell Biol. 63, 89-106 (2001).
3. Rao, J., Seligson, D. & Hemstreet, G.P. Protein expression analysis using quantitative fluorescence image analysis on tissue microarray slides. Biotechniques 32, 924-932 (2002).
4. Bacus, S. et al. Potential use of image analysis for the evaluation of cellular predicting factors for therapeutic response in breast cancers. Anal. Quant. Cytol. Histol. 19, 316-328 (1997).
5. Kallioniemi, O.P., Wagner, U., Kononen, J. & Sauter, G. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum. Mol. Genet. 10, 657-662 (2001).
6. Kononen, J. et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nature Med. 4, 844-847 (1998).
7. Rimm, D.L. et al. Tissue microarray: A new technology for amplification of tissue resources. Cancer J. 7, 24-31 (2001).
8. Osborne, C.K. et al. Estrogen receptor, a marker for human breast cancer differentiation and patient prognosis. Adv. Exp. Med. Biol. 138, 377-385 (1981).
9. Wasson, J.H., Sox, H.C., Neff, R.K. & Goldman, L. Clinical prediction rules. Applications and methodological standards. N. Engl. J. Med. 313, 793-799 (1985).
10. Kobayashi, M. et al. Nuclear translocation of β-catenin in colorectal cancer. Br. J. Cancer 82, 1689-1693 (2000).
11. Provost, E. & Rimm, D.L. Controversies at the cytoplasmic face of the cadherinbased adhesion complex. Curr. Opin. Cell Biol. 11, 567-572 (1999).
12. Morin, P.J. β-catenin signaling and cancer. Bioessays 21, 1021-1030 (1999).
13. Peifer, M. & Polakis, P. Wnt signaling in oncogenesis and embryogenesis - A look outside the nucleus. Science 287, 1606-1609 (2000).
14. Wong, C.M., Fan, S.T. & Ng, I.O. β-catenin mutation and overexpression in hepatocellular carcinoma: Clinicopathologic and prognostic significance. Cancer 92, 136-145 (2001).
15. Gunther, K. et al. Predictive value of nuclear β-catenin expression for the occurrence of distant metastases in rectal cancer. Dis. Colon Rectum 41, 1256-1261 (1998).
16. Maruyama, K. et al. Cytoplasmic β-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer. Oncology 59, 302-309 (2000).
17. Hugh, T.J. et al. Beta-catenin expression in primary and metastatic colorectal carcinoma. Int. J. Cancer 82, 504-511 (1999).
18. Chung, G.G. et al. Tissue microarray analysis of β-catenin in colorectal cancer shows nuclear phospho-β-catenin is associated with a better prognosis. Clin. Cancer Res. 7, 4013-4020 (2001).
19. Lin, S.Y. et al. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nature Cell Biol. 3, 802-808 (2001).